News

The drug is a ready-to-use version of The Medicines Co’s blood clot preventer Angiomax, which should also to be taken with aspirin. It is intended for use as

These data showed the BRIDGE study met the primary endpoint, demonstrating a statistically significant increase in bone mineral density (BMD) at the lumbar spine (as assessed by dual

Under the new arrangement, Helsinn Therapeutics Inc., the U.S. affiliate of Helsinn, will obtain exclusive rights to promote and sell AKYNZEO (netupitant/palonosetron), its oral fixed dose combination product

"Changes at InVivo Therapeutics after I left the company in August of 2013 have permanently limited wide market adoption of my first generation of NeuroScaffolds. PixarBio’s Novel NR-SCI

In the Octave Induction 1 and Octave Induction 2 studies, tofacitinib reduced symptoms of moderate to severe UC and induced remission of the disease. In one study, 18.5%

The FDA has set a target action date under the Prescription Drug User Fee Act ("PDUFA") of July 14, 2016. SequestOxTM is an immediate-release Oxycodone Hydrochloride containing sequestered

Financial terms of the transaction were not disclosed. "This transaction gives us the opportunity to economically benefit from the antibiotic assets in our infectious disease portfolio and to

Osteogenesis imperfecta, also known as brittle bone disease or Lobstein syndrome, affects how the body produces collagen, a protein that helps strengthen bones. OI is often lethal before

This decision overturns FDA’s previous position reached at a lower level and clears the path toward approval for Travivo, an antidepressant with a unique mechanism of action and